Lymphocytes usually differentiate into effector cells within days after antigen exposure, except in germinal centers where terminal differentiation is delayed while somatic hypermutation creates high-affinity antibody mutants. Here we investigate whether arrest of terminal differentiation can be mediated by BCL-6, a transcriptional repressor that is expressed by germinal center B cells and is required for this phase of B cell development. We find that BCL-6 suppresses the differentiation of transformed and primary B cells to plasma cells by inhibiting the signal transducer and activator of transcription 3–dependent expression of the major regulator of plasma cell development, the B lymphocyte–induced maturation protein (Blimp-1). This function of BCL-6 as a repressor of B lymphocyte differentiation may also underlie the association between chromosomal translocations of its gene and B cell lymphomas.
Skip Nav Destination
Article navigation
18 December 2000
Brief Definitive Report|
December 18 2000
Suppression of Signal Transducer and Activator of Transcription 3–Dependent B Lymphocyte Terminal Differentiation by Bcl-6
Rajko Reljic,
Rajko Reljic
aWellcome Trust Immunology Unit, University of Cambridge, School of Clinical Medicine, Cambridge CB2 2SP, United Kingdom
Search for other works by this author on:
Simon D. Wagner,
Simon D. Wagner
aWellcome Trust Immunology Unit, University of Cambridge, School of Clinical Medicine, Cambridge CB2 2SP, United Kingdom
bDepartment of Haematology, Addenbrookes Hospital, Cambridge CB2 2SP, United Kingdom
Search for other works by this author on:
Luke J. Peakman,
Luke J. Peakman
aWellcome Trust Immunology Unit, University of Cambridge, School of Clinical Medicine, Cambridge CB2 2SP, United Kingdom
Search for other works by this author on:
Douglas T. Fearon
Douglas T. Fearon
aWellcome Trust Immunology Unit, University of Cambridge, School of Clinical Medicine, Cambridge CB2 2SP, United Kingdom
Search for other works by this author on:
Rajko Reljic
aWellcome Trust Immunology Unit, University of Cambridge, School of Clinical Medicine, Cambridge CB2 2SP, United Kingdom
Simon D. Wagner
aWellcome Trust Immunology Unit, University of Cambridge, School of Clinical Medicine, Cambridge CB2 2SP, United Kingdom
bDepartment of Haematology, Addenbrookes Hospital, Cambridge CB2 2SP, United Kingdom
Luke J. Peakman
aWellcome Trust Immunology Unit, University of Cambridge, School of Clinical Medicine, Cambridge CB2 2SP, United Kingdom
Douglas T. Fearon
aWellcome Trust Immunology Unit, University of Cambridge, School of Clinical Medicine, Cambridge CB2 2SP, United Kingdom
R. Reljic and S.D. Wagner contributed equally to this work.
Received:
September 25 2000
Revision Requested:
October 23 2000
Accepted:
October 24 2000
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Exp Med (2000) 192 (12): 1841–1848.
Article history
Received:
September 25 2000
Revision Requested:
October 23 2000
Accepted:
October 24 2000
Citation
Rajko Reljic, Simon D. Wagner, Luke J. Peakman, Douglas T. Fearon; Suppression of Signal Transducer and Activator of Transcription 3–Dependent B Lymphocyte Terminal Differentiation by Bcl-6. J Exp Med 18 December 2000; 192 (12): 1841–1848. doi: https://doi.org/10.1084/jem.192.12.1841
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement